Aminoglycoside Dosage Regimens After Therapeutic Drug Monitoring

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.41, Iss.10, 2002-01, pp. : 791-792

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Individualising Aminoglycoside Dosage Regimens after Therapeutic Drug Monitoring: Simple or Complex Pharmacokinetic Methods?

By Tod M.M.

Clinical Pharmacokinetics, Vol. 40, Iss. 11, 2001-01 ,pp. : 803-814

Adis International

Access to resources Recommend Favorite

Aminoglycoside Adaptive Resistance: Importance for Effective Dosage Regimens

By Barclay M.L. Begg E.J.

Drugs, Vol. 61, Iss. 6, 2001-01 ,pp. : 713-721

Adis International

Access to resources Recommend Favorite

Economic Impact of Aminoglycoside Toxicity and its Prevention Through Therapeutic Drug Monitoring

By Slaughter R.L. Cappelletty D.M.

PharmacoEconomics, Vol. 14, Iss. 4, 1998-10 ,pp. : 385-394

Adis International

Access to resources Recommend Favorite

Doctors’ perspectives towards a bedside aminoglycoside therapeutic drug monitoring service: a collaboration between pharmacy and clinical pharmacology

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 45, Iss. 2, 2015-06 ,pp. : 159-165

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic drug monitoring (TDM) and/or pharmacogenetic tests may be useful in devising individualised drug therapy regimens

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 23, Iss. 6, 2007-06 ,pp. : 22-26

Adis International

Access to resources Recommend Favorite